3rd Quarter - Report

THE MCMANUS GROUP for ELI LILLY AND COMPANY

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Support for H.R. 1548, "Pathway for Biosimilars Act." Opposition to H.R. 1427, "Promoting Innovation and Access to Life-Saving Medicine Act." Follow-on biologics provisions in H.R. 3200, "America's Affordable Health Choices Act of 2009" and S. ____, "America's Healthy Future Act." Comparative effectiveness provisions in H.R. 3200, "America's Affordable Health Choices Act of 2009" and S. ____, "America's Healthy Future Act."

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1427 (111th), H.R. 1548 (111th), H.R. 3200 (111th)

Medicare/Medicaid MMM

Opposition to Medicare rebates in S. ____, "America's Healthy Future Act," and H.R. 3200, "America's Affordable Health Choices Act of 2009."

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3200 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.